Clarius Group LLC’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.7K | Hold |
16,080
| – | – | ﹤0.01% | 478 |
|
|
2025
Q1 | $32K | Hold |
16,080
| – | – | ﹤0.01% | 480 |
|
|
2024
Q4 | $47K | Hold |
16,080
| – | – | ﹤0.01% | 448 |
|
|
2024
Q3 | $62.2K | Hold |
16,080
| – | – | ﹤0.01% | 449 |
|
|
2024
Q2 | $82.7K | Hold |
16,080
| – | – | 0.01% | 439 |
|
|
2024
Q1 | $113K | Hold |
16,080
| – | – | 0.01% | 471 |
|
|
2023
Q4 | $142K | Hold |
16,080
| – | – | 0.01% | 464 |
|
|
2023
Q3 | $153K | Hold |
16,080
| – | – | 0.01% | 443 |
|
|
2023
Q2 | $236K | Hold |
16,080
| – | – | 0.02% | 453 |
|
|
2023
Q1 | $198K | Hold |
16,080
| – | – | 0.02% | 483 |
|
|
2022
Q4 | $299K | Buy |
+16,080
| New | +$299K | 0.03% | 385 |
|